ACCESS Newswire

    / Wellgistics Health, Inc. (“Wellgistics” or the “Company”) (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent (“LOI”) to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization.

    Latest News

    – UAE President His Highness Sheikh Mohamed bin Zayed Al Nahyan held talks with French President Emmanuel Macron in Abu Dhabi on October 19 on expanding the strategic partnership between their countries. The meeting came during Macron’s official visit to